These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
547 related articles for article (PubMed ID: 22267310)
1. Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling. Guihard P; Danger Y; Brounais B; David E; Brion R; Delecrin J; Richards CD; Chevalier S; Rédini F; Heymann D; Gascan H; Blanchard F Stem Cells; 2012 Apr; 30(4):762-72. PubMed ID: 22267310 [TBL] [Abstract][Full Text] [Related]
2. Oncostatin M promotes osteogenesis and suppresses adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells. Song HY; Jeon ES; Kim JI; Jung JS; Kim JH J Cell Biochem; 2007 Aug; 101(5):1238-51. PubMed ID: 17226768 [TBL] [Abstract][Full Text] [Related]
3. Oncostatin m, an inflammatory cytokine produced by macrophages, supports intramembranous bone healing in a mouse model of tibia injury. Guihard P; Boutet MA; Brounais-Le Royer B; Gamblin AL; Amiaud J; Renaud A; Berreur M; Rédini F; Heymann D; Layrolle P; Blanchard F Am J Pathol; 2015 Mar; 185(3):765-75. PubMed ID: 25559270 [TBL] [Abstract][Full Text] [Related]
4. Oncostatin M is a growth factor for Ewing sarcoma. David E; Tirode F; Baud'huin M; Guihard P; Laud K; Delattre O; Heymann MF; Heymann D; Redini F; Blanchard F Am J Pathol; 2012 Nov; 181(5):1782-95. PubMed ID: 22982441 [TBL] [Abstract][Full Text] [Related]
5. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors. Malaval L; Liu F; Vernallis AB; Aubin JE J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3. Chipoy C; Berreur M; Couillaud S; Pradal G; Vallette F; Colombeix C; Rédini F; Heymann D; Blanchard F J Bone Miner Res; 2004 Nov; 19(11):1850-61. PubMed ID: 15476586 [TBL] [Abstract][Full Text] [Related]
8. Discovering small molecules that inhibit adipogenesis and promote osteoblastogenesis: unique screening and Oncostatin M-like activity. Nawa K; Ikeno H; Matsuhashi N; Ogasawara T; Otsuka E Differentiation; 2013; 86(1-2):65-74. PubMed ID: 23995451 [TBL] [Abstract][Full Text] [Related]
9. The effect of TNFα secreted from macrophages activated by titanium particles on osteogenic activity regulated by WNT/BMP signaling in osteoprogenitor cells. Lee SS; Sharma AR; Choi BS; Jung JS; Chang JD; Park S; Salvati EA; Purdue EP; Song DK; Nam JS Biomaterials; 2012 Jun; 33(17):4251-63. PubMed ID: 22436801 [TBL] [Abstract][Full Text] [Related]
10. Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation. Nicolaidou V; Wong MM; Redpath AN; Ersek A; Baban DF; Williams LM; Cope AP; Horwood NJ PLoS One; 2012; 7(7):e39871. PubMed ID: 22802946 [TBL] [Abstract][Full Text] [Related]
11. Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor. Persson E; Souza PPC; Floriano-Marcelino T; Conaway HH; Henning P; Lerner UH Front Immunol; 2019; 10():1164. PubMed ID: 31191537 [No Abstract] [Full Text] [Related]
12. Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat. Kha HT; Basseri B; Shouhed D; Richardson J; Tetradis S; Hahn TJ; Parhami F J Bone Miner Res; 2004 May; 19(5):830-40. PubMed ID: 15068507 [TBL] [Abstract][Full Text] [Related]
13. Leukemia inhibitory factor contributes to hepatocyte-like differentiation of human bone marrow mesenchymal stem cells. Lysy PA; Smets F; Najimi M; Sokal EM Differentiation; 2008 Dec; 76(10):1057-67. PubMed ID: 18557762 [TBL] [Abstract][Full Text] [Related]
14. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation. Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780 [TBL] [Abstract][Full Text] [Related]
15. A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation. Itoh S; Udagawa N; Takahashi N; Yoshitake F; Narita H; Ebisu S; Ishihara K Bone; 2006 Sep; 39(3):505-12. PubMed ID: 16679075 [TBL] [Abstract][Full Text] [Related]
16. IL-3 promotes osteoblast differentiation and bone formation in human mesenchymal stem cells. Barhanpurkar AP; Gupta N; Srivastava RK; Tomar GB; Naik SP; Joshi SR; Pote ST; Mishra GC; Wani MR Biochem Biophys Res Commun; 2012 Feb; 418(4):669-75. PubMed ID: 22293197 [TBL] [Abstract][Full Text] [Related]
17. Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes. Gharibi B; Abraham AA; Ham J; Evans BA J Bone Miner Res; 2011 Sep; 26(9):2112-24. PubMed ID: 21590734 [TBL] [Abstract][Full Text] [Related]
18. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415 [TBL] [Abstract][Full Text] [Related]
19. The role of noggin in human mesenchymal stem cell differentiation. Rifas L J Cell Biochem; 2007 Mar; 100(4):824-34. PubMed ID: 17133353 [TBL] [Abstract][Full Text] [Related]
20. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo. Walker EC; Poulton IJ; McGregor NE; Ho PW; Allan EH; Quach JM; Martin TJ; Sims NA J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]